Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Brain Neoplasms × Fentanyl × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 12 Neoplasms 6 Colonic Neoplasms 5 Agnosia 5 Cancer Pain 4 Breast Neoplasms 4 Rectal Neoplasms 3 Prostatic Neoplasms 3 Pain, Postoperative 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Pancreatic Neoplasms 2 Lymphoma, Follicular 2 Diverticulosis, Colonic 2 Chronic Pain 2 Breakthrough Pain 2 post laminectomy syndrome 1 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thrombocythemia, Essential 1 Terminal Cancer 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1

Interventions

Radiosurgery 99 Temozolomide 86 Bevacizumab 60 Magnetic Resonance Spectroscopy 59 Radiotherapy 52 Carboplatin 27 pembrolizumab 26 Irinotecan 22 Nivolumab 21 Surgical Procedures, Operative 20 Magnetic Resonance Imaging 19 Etoposide 19 Surveys and Questionnaires 18 Ipilimumab 18 Cyclophosphamide 18 Radiation 17 Erlotinib Hydrochloride 17 Aminolevulinic Acid 17 Specimen Handling 15 Pemetrexed 15 Cisplatin 13 Carmustine 13 Neuropsychological Tests 12 Mental Status and Dementia Tests 12 Topotecan 11 Filgrastim 10 Drug Therapy 10 Dexmedetomidine 10 Capecitabine 10 Trastuzumab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07165262 2025-09-10

ECOG-Anaes

Children's Cancer Hospital Egypt 57357

Phase 3 Active not recruiting

Brain Neoplasms, Epilepsy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡